Skip to main content

Advertisement

SpringerLink
Log in

Adjuvant treatment modalities to control macular edema in diabetic patients undergoing cataract surgery

  • Review
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Cataract surgical outcomes in diabetic patients has been subject to changes with the advances in the surgical techniques. Recent studies suggest that cataract surgery does not cause the progression of diabetic retinopathy and intravitreal bevacizumab and/or triamcinolone injections combined with cataract surgery may contribute in short term improvement of macular edema in diabetic patients. This article reviews the progression of diabetic retinopathy after cataract surgery with phacoemulsification and the use of adjuvant intravitreal treatments combined with phacoemusification in diabetic patients undergoing cataract surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dowler JG, Sehmi KS, Hykin PG, Hamilton AM (1999) The natural history of macular edema after cataract surgery in diabetes. Ophthalmology 106:663–668

    Article  PubMed  CAS  Google Scholar 

  2. Kim SJ, Equi R, Bressler NM (2007) Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology 114(5):881–889

    Article  PubMed  Google Scholar 

  3. Liao SB, Ku WC (2003) Progression of diabetic retinopathy after phacoemulsification in diabetic patients: a 3-year analysis. Chang Gung Med J 26(11):829–834

    PubMed  Google Scholar 

  4. Chew EY, Benson WE, Remaley NA, Lindley AA, Burton TC, Csaky K, Williams GA, Ferris FL 3rd (1999) Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25. Arch Ophthalmol 117(12):1600–1606

    Article  PubMed  CAS  Google Scholar 

  5. Sze-Un Fong C, Mitchell P, Rochtchina E, de Loryn T, Hong T, Jin Wang J (2010) Visual outcomes 12 months after phacoemulsification cataract surgery in patients with diabetes. Acta Ophthalmol. Feb 16. [Epub ahead of print]

  6. Hong T, Mitchell P, de Loryn T, Rochtchina E, Cugati S, Wang JJ (2009) Development and progression of diabetic retinopathy 12 months after phacoemulsification cataract surgery. Ophthalmology 116(8):1510–1514

    Article  PubMed  Google Scholar 

  7. Krepler K, Biowski R, Schrey S, Jandrasits K, Wedrich A (2002) Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol 240(9):735–738

    Article  PubMed  Google Scholar 

  8. Romero-Aroca P, Fernández-Ballart J, Almena-Garcia M, Méndez-Marín I, Salvat-Serra M, Buil-Calvo JA (2006) Nonproliferative diabetic retinopathy and macular edema progression after phacoemulsification: prospective study. J Cataract Refract Surg 32(9):1438–1444

    Article  PubMed  Google Scholar 

  9. Squirrell D, Bhola R, Bush J, Winder S, Talbot JF (2002) A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Br J Ophthalmol 86(5):565–571

    Article  PubMed  CAS  Google Scholar 

  10. Kwon SI, Hwang DJ, Seo JY, Park IW (2011) Evaluation of changes of macular thickness in diabetic retinopathy after cataract surgery. Korean J Ophthalmol 25(4):238–242

    Article  PubMed  Google Scholar 

  11. Eriksson U, Alm A, Bjärnhall G, Granstam E, Matsson AW (2011) Macular edema and visual outcome following cataract surgery in patients with diabetic retinopathy and controls. Graefes Arch Clin Exp Ophthalmol 249(3):349–359

    Article  PubMed  Google Scholar 

  12. Pollack A, Leiba H, Bukelman A, Oliver M (1992) Cystoid macular oedema following cataract extraction in patients with diabetes. Br J Ophthalmol 76:221–224

    Article  PubMed  CAS  Google Scholar 

  13. Takamura Y, Kubo E, Akagi Y (2009) Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery. Ophthalmology 116(6):1151–1157

    Article  PubMed  Google Scholar 

  14. Lanzagorta-Aresti A, Palacios-Pozo E, Menezo Rozalen JL, Navea-Tejerina A (2009) Prevention of vision loss after cataract surgery in diabetic macular edema with intravitreal bevacizumab: a pilot study. Retina 29(4):530–535

    Article  PubMed  Google Scholar 

  15. Chen CH, Liu YC, Wu PC (2009) The combination of intravitreal bevacizumab and phacoemulsification surgery in patients with cataract and coexisting diabetic macular edema. J Ocul Pharmacol Ther 25(1):83–89

    Article  PubMed  CAS  Google Scholar 

  16. Cheema RA, Al-Mubarak MM, Amin YM, Cheema MA (2009) Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy: prospective randomized study. J Cataract Refract Surg 35(1):18–25

    Article  PubMed  Google Scholar 

  17. Akinci A, Batman C, Ozkilic E, Altinsoy A (2009) Phacoemulsification with intravitreal bevacizumab injection in diabetic patients with macular edema and cataract. Retina 29(10):1432–1435

    Article  PubMed  Google Scholar 

  18. Wahab S, Ahmed J (2010) Management of cataract with macular oedema due to diabetes mellitus type-II and hypertension with grid laser prior to surgery and intra-vitreal bevacizumab (Avastin) peroperatively. J Pak Med Assoc 60(10):836–839

    PubMed  Google Scholar 

  19. Fard MA, Yazdanei Abyane A, Malihi M (2011) Prophylactic intravitreal bevacizumab for diabetic macular edema (thickening) after cataract surgery: prospective randomized study. Eur J Ophthalmol 21(3):276–281

    Article  PubMed  Google Scholar 

  20. Habib MS, Cannon PS, Steel DH (2005) The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract. BMC Ophthalmol 22(5):15

    Article  Google Scholar 

  21. Lam DS, Chan CK, Mohamed S, Lai TY, Lee VY, Lai WW, Fan DS, Chan WM (2005) Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6-month prospective pilot study. Eye (Lond) 19(8):885–890

    Article  CAS  Google Scholar 

  22. Akinci A, Muftuoglu O, Altınsoy A, Ozkılıc E (2011) Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract. 31 4:755–758

    Google Scholar 

  23. Kim SY, Yang J, Lee YC, Park YH (2008) Effect of a single intraoperative sub-tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery. J Cataract Refract Surg 34(5):823–826

    Article  PubMed  Google Scholar 

  24. Takata C, Messias A, Folgosa MS, Lucena LR, Lucena DR, Scott IU, Jorge R (2010) Intravitreal injection versus subtenon infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema. Retina 30(4):562–569

    Article  PubMed  Google Scholar 

  25. Diabetic Retinopathy Clinical Research Network (DRCR.net), Beck RW, Edwards AR, Aiello LP, Bressler NM, Ferris F, Glassman AR, Hartnett E, Ip MS, Kim JE, Kollman C (2009) Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol 127(3):245–251

    Article  PubMed  Google Scholar 

  26. Elman MJ, Bressler NM, Qin H, Beck RW, Ferris FL 3rd, Friedman SM, Glassman AR, Scott IU, Stockdale CR, Sun JK, Diabetic Retinopathy Clinical Research Network (2011) Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 118(4):609–614

    Article  PubMed  Google Scholar 

  27. Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, Sutter F, Simader C, Burian G, Gerstner O, Weichselberger A, RESTORE study group (2011) The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118(4):615–625

    Article  PubMed  Google Scholar 

  28. Rauen PI, Ribeiro JA, Almeida FP, Scott IU, Messias A, Jorge R (2012) Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic macular edema. Retina 32(9):1799–1803

    PubMed  CAS  Google Scholar 

  29. Udaondo P, Garcia-Pous M, Garcia-Delpech S, Salom D, Diaz-Llopis M (2011) Prophylaxis of macular edema with intravitreal ranibizumab in patients with diabetic retinopathy after cataract surgery: a pilot study. J Ophthalmol 2011:159436

    PubMed  Google Scholar 

  30. Shah AS, Chen SH (2010) Cataract surgery and diabetes. Curr Opin Ophthalmol 21(1):4–9

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Mark Wilkins for English editing.

Conflict of interest

The authors disclose no proprietary interest or financial support or conflict of interest. This submission has not been presented or published anywhere previously and it is not simultaneously being considered for any other publication.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Faculty of Medicine, Pamukkale University, Göz Hastalıkları AD, Kınıklı Kampüsü, Kınıklı, Denizli, Turkey

    Ebru Nevin Cetin & Cem Yıldırım

Authors
  1. Ebru Nevin Cetin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cem Yıldırım
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ebru Nevin Cetin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cetin, E.N., Yıldırım, C. Adjuvant treatment modalities to control macular edema in diabetic patients undergoing cataract surgery. Int Ophthalmol 33, 605–610 (2013). https://doi.org/10.1007/s10792-012-9695-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-012-9695-1

Keywords

Search

Navigation